ILMN Illumina Inc.

Illumina To Webcast Upcoming Investor Conference

Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:

  • Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

    Fireside Chat at 7:30 am Pacific Time / 10:30 am Eastern Time

The live webcast can be accessed under the Investor Info section of the "company" tab at . A replay will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

EN
27/05/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Illumina Inc.

Illumina Inc: 1 director

A director at Illumina Inc bought 7,330 shares at 135.290USD and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

Illumina, Inc.: Update following outlook revision to negative

Our credit view of this issuer reflects its long standing client relationships, offset by its significant operating losses at GRAIL.

Moody's revises Illumina's outlook to negative; affirms Baa3 rating

Moody's Investors Service ("Moody's") has revised the outlook of Illumina, Inc. ("Illumina") to negative from stable. Concurrently, Moody's affirmed Illumina's Baa3 issuer and senior unsecured ratings. The revision of the outlook to negative reflects Moody's expectation that Illumina will operate ...

Moody's assigns Baa3 rating to Illumina's notes offering

Moody's Investors Service, ("Moody's") assigned a Baa3 rating to the proposed offering of $1 billion of senior unsecured notes of Illumina, Inc ("Illumina"). There are no changes to Illumina's existing Baa3 issuer rating or the stable outlook. Proceeds of the offering will be used to repay upcomin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch